Study of Rocuronium Onset Time According to Remifentanil Infusion
- Conditions
- Anesthesia
- Interventions
- Drug: the order of drug administration
- Registration Number
- NCT01030510
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
The investigators therefore hypothesized that remifentanil could prolong the onset time of rocuronium, and evaluated the effect of remifentanil on the hemodynamic profiles (arterial pressure and heart rate) during the anesthetic induction sequence.
- Detailed Description
It has been reported that co-administration of ephedrine reduced the onset time of neuromuscular block of rocuronium (1-3). It also provided an improved condition for the rapid tracheal intubation (2,4). This beneficial effect was attributed to the increased cardiac output and tissue perfusion to muscle, and therefore, a more rapid delivery of rocuronium to the neuromuscular junction was achieved (4-5). If so, any drugs which decrease cardiac output consequently can prolong the onset time of rocuronium.
Remifentanil is the first ultra-short acting opioid with a rapid onset. During the total intravenous anesthesia (TIVA) with propofol and remifentanil, prior administration of remifentanil could reduce the propofol infusion pain without other significant complications (6). However, remifentanil can decrease the arterial pressure and heart rate (7-8), so that it is likely to decrease the onset time of rocuronium for the opposite principle that ephedrine increases it.
The investigators therefore hypothesized that remifentanil could prolong the onset time of rocuronium, and evaluated the effect of remifentanil on the hemodynamic profiles (arterial pressure and heart rate) during the anesthetic induction sequence.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 126
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description group R the order of drug administration In group R, remifentanil was infused first before administrating propofol and rocuronium group P the order of drug administration in group P, remifentanil was administered last after the propofol and rocuronium injection
- Primary Outcome Measures
Name Time Method the onset time of rocuronium 3 minutes [after injection of rocuronium when general anesthesia is induced.] Onset time of rocuronium was defined as the time from the end of its injection to the 95% depression of single twitch response, and it was measured by an anaesthesiologist, unaware of the group allocation.
- Secondary Outcome Measures
Name Time Method mean arterial pressure (MAP) 15 minutes [4 times; during the induction of general anesthesia as described below.] 1. before induction (baseline): When a patient enter the operating room,
2. at rocuronium administration: immediately before injecting rocuronium,
3. before tracheal intubation: immediately before intubation,
4. after tracheal intubation: immediately after intubation.heart rate (HR) 15 minutes [4 times; during the induction of general anesthesia as described below.] 1. before induction (baseline): When a patient enter the operating room,
2. at rocuronium administration: immediately before injecting rocuronium,
3. before tracheal intubation: immediately before intubation,
4. after tracheal intubation: immediately after intubation.cardiac output 15 minutes [4 times; during the induction of general anesthesia as described below.] 1. before induction (baseline): When a patient enter the operating room,
2. at rocuronium administration: immediately before injecting rocuronium,
3. before tracheal intubation: immediately before intubation,
4. after tracheal intubation: immediately after intubation.pain from the propofol infusion 1 minute [at the time when propofol is administered.] When propofol is administered for the induction of anesthesia, we investigate the pain by propofol.
cough or chest wall rigidity from the remifentanil infusion 1 minute [at the time when remifentanil is infused.] when remifentanil is infused, the cough or chest wall rigidity is checked.
Trial Locations
- Locations (1)
Seoul National University Bundang Hospital
🇰🇷Seongnam-si, Gyeonggi-do, Korea, Republic of